Navigation Links
Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence
Date:4/14/2009

Commercial Managed Care - Managed care plans come in many varieties and serve different purposes. This course looks at the characteristics of the different types of managed care organizations (MCOs), the different types of benefit and formulary design, the various mechanisms that plans use to manage drug utilization and costs, the impact of patent expiration and generic utilization on branded products, tactics health plans use to drive generic utilization, and potential future trends in managed care.
  • Medicare - With the launch of the Medicare Part D drug benefit, Medicare's impact on pharmaceutical and biologic product sales has dramatically increased. This course provides team members with the necessary background to understand and effectively sell to this segment of the market, including the four key components of Medicare: Parts A, B, C, & D, the characteristics of the Medicare population, the current structure and potential changes to the Part D drug benefit, and the common questions about the Medicare program.
  • Medicaid - The role and importance of Medicaid has been transformed by the Medicare Part D drug benefit. This course helps team members understand how this program has evolved and how it is managed. Topics covered in this course include, understanding the characteristics of the Medicaid population, changes to Medicaid as a result of Medicare Part D, the role of preferred drugs lists in Medicaid utilization management, and the priorities and challenges for the government in managing and paying for drugs.
  • Specialty Pharmacy - Specialty products are under increasing financial pressure in the current reimbursement environment. This course helps team members understand the management structure and economics of a physician practice that utilizes specialty products, including the day-to-day roles and responsibilities of practice managers, as well as their key challenges, the
    '/>"/>

  • SOURCE Pharmaceutical Institute
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Researchs 100th Annual Meeting
    2. Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals
    3. Process Analytical Technology (PAT): The Official Language of Pharmaceutical Outsourcing
    4. Marinus Pharmaceuticals Raises $20 Million in Series B Financing
    5. OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia
    6. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
    7. Gemin X Pharmaceuticals Selects and Deploys Clinical Force CTMS
    8. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
    9. VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
    10. Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier
    11. Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2014)... 29, 2014 /PRNewswire-iReach/ -- Nanosyn, Inc. announced today ... Inc., to provide access to Nanosyn,s microfluidics screening ... platform for novel small molecule therapeutics. ... to work with FORMA Therapeutics to explore key ... homeostasis. FORMA Therapeutics, decision to work with us ...
    (Date:7/29/2014)... 2014 TransVac Solutions, the trusted leader ... transport solutions for hospitals, will be exhibiting at booth ... Annual Conference & Technical Exhibition Aug. 3-6 in Chicago, ... for making hospitals cleaner, reducing infection risk and saving ... life cycle. Staff will be available at booth ...
    (Date:7/29/2014)... 2014  Sigma-Aldrich Corporation (NASDAQ: SIAL ) ... its investment in Green Chemistry and donated more than ... year, the Company announced Monday in its new ... World? The report comes in a ... a responsible corporate citizen, including recognition for the second ...
    (Date:7/29/2014)... 29, 2014 G-CON Manufacturing Inc., the ... today announced a new leadership appointment designed to drive ... and abroad. , Maik Jornitz, Chief Operating Officer ... President charged with leading the pioneering company through its ... this stage of development and look forward to providing ...
    Breaking Biology Technology:Nanosyn Announces Expanded Partnership With FORMA Therapeutics 2TransVac Presents Cost Saving Technology at ASHE Conference for Keeping Hospitals Cleaner 2Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 2Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 3G-CON Manufacturing, Inc. Announces Maik Jornitz as President 2
    ... May 22 Advance Nanotech, Inc., (OTC,Bulletin Board: AVNA), ... selected as one of four finalists for the 2008 ... for,innovation in engineering. HRH the Duke of Edinburgh will ... medal to the winner of this year,s,competition at the ...
    ... Inc. (Nasdaq and SWX: BMRN) will host a ... Thursday, June 5, 2008 from,7:30 a.m. to 11:30 ... New York City. Members,of BioMarin,s senior management team ... new information about advancements in the,research and development ...
    ... Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today ... REOLYSIN(R) at the 40-litre,batch size to SAFC ... the successful scale-up from 20 litres to ... Yields at the 40-litre scale should ...
    Cached Biology Technology:Advance Nanotech's Owlstone Subsidiary Selected as One of Four Finalists in The 2008 Royal Academy of Engineering MacRobert Awards Competition 2Advance Nanotech's Owlstone Subsidiary Selected as One of Four Finalists in The 2008 Royal Academy of Engineering MacRobert Awards Competition 3Advance Nanotech's Owlstone Subsidiary Selected as One of Four Finalists in The 2008 Royal Academy of Engineering MacRobert Awards Competition 4BioMarin to Host Research and Development Day June 5th 2Oncolytics Biotech Inc. Transfers 40-Litre cGMP Manufacturing Process for REOLYSIN(R) 2Oncolytics Biotech Inc. Transfers 40-Litre cGMP Manufacturing Process for REOLYSIN(R) 3
    (Date:7/29/2014)... Maryland Schools of Dentistry (UM SOD) and Medicine ... received a five-year $10.7 million grant award from ... (NIAID) of the National Institutes of Health to ... diseases (STDs). The grant, which renews a previous ... new direction for the research by studying chlamydial ...
    (Date:7/29/2014)... PARIS, 29 JULY 2014 With thirty days to ... for the FEBS-EMBO 2014 Conference are well underway. The ... Biochemical Societies (FEBS), EMBO, and the French Society for ... Saturday, 30 August to Thursday, 4 September at the ... 2014 Conference is the largest meeting for the life ...
    (Date:7/29/2014)... 1 in 100,000 people characterized by a loss of ... unknown, a new study by a team of researchers at ... and other European institutions confirms for the first time that ... July in Nature Genetics , is an important step ... sphincter in the lower esophagus opens, allowing food to enter ...
    Breaking Biology News(10 mins):University of Maryland Schools of Dentistry and Medicine receive NIH grant 2University of Maryland Schools of Dentistry and Medicine receive NIH grant 3University of Maryland Schools of Dentistry and Medicine receive NIH grant 4Counting down to FEBS-EMBO 2014 in Paris, France 2Mysterious esophagus disease is autoimmune after all 2
    ... with Sartorius Stedim Biotech (SSB) and Adolf Kühner AG ... 2009 , ,Monthey, 19. Mai 2009 / b3c ... contract manufacturing to the biopharmaceutical industry, expands its product ... bioreactor. OrbShake bioreactors rely on orbital shaking ...
    ... plants into a renewable, nonpolluting replacement for crude oil. ... convert plant biomass into a building block for plastics ... have successfully converted cellulose -- the most common plant ... in one step. The result builds upon ...
    ... recently awarded 13 grants totaling more than $191,000 ... Grant proposals were reviewed during SIR,s 34th Annual ... Foundation is proud to be able to contribute ... SIR Foundation grant program is designed to benefit ...
    Cached Biology News:ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor 2ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor 3Plastic that grows on trees, part two 2Society of Interventional Radiology Foundation awards $191,000 in grants 2Society of Interventional Radiology Foundation awards $191,000 in grants 3